D-FICA125D10/D-FICA125D25–CA125 Test Device

Intended use:

The CA125 Test Device (Whole Blood/Serum/Plasma) is intended for the in vitro quantitative detection of Cancer Antigen 125 (CA125) in human whole blood, serum or plasma, as an aid in diagnosis and treatment monitoring of ovarian cancer.

Principle:The CA125 Test Device (Whole Blood/Serum/Plasma) is detects CA125 antigen based on Fluorescence Immunoassay. The sample moves through the strip from sample pad to absorbent pad. If the specimen contains CA125 antigen, it attaches to the fluorescence microspheres-conjugated CA125 antibodies. Then the complex will be captured by the capture antibodies coated on the nitrocellulose membrane (Test line). The concentration of CA125 antigen in the sample correlates linearly with the fluorescence signal intensity captured on the T line. According to the fluorescence intensity of the test and standard curve, the concentration of CA125 antigen in the sample can be calculated by the analyzer to show CA125 antigen concentration in specimen.

Product Features:
Extraordinary Sensitivity
High Accuracy
Wide Dynamic Range
Extensive Range of Applications

 

Cat NO.

D-FICA125D10/D-FICA125D25

Storage Temperature

t 2-30 °C

Reading Time

15 minutes

Specimen

Finger prick blood, WB/S/P

Test Range

5-600 U/mL

CE Status

CE

ENQUIRE ABOUT THIS PRODUCT

    Product

    Sku

    Name (required)

    Country (required)

    Company

    Email (required)

    Message

    Additional information

    Cat NO.

    D-FICA125D10/D-FICA125D25

    Storage Temperature

    t 2-30 °C

    Reading Time

    15 minutes

    Specimen

    Finger prick blood, WB/S/P

    Test Range

    5-600 U/mL

    CE Status

    CE